MRRPhysical AI
intelligence
← Company intelligence

Robot maker · registered

Sinovation Medical (HKHS)

Corporate marketmedicalCurated record
sinovationmed.com

Neurosurgical robotics maker (SR series / Sinobot X1, Q300 miniature robot) for stereotactic procedures such as SEEG electrode placement and brain biopsy; robot-assisted biopsy showed 98% diagnostic rate with significantly shorter operating time versus frame-based methods. NMPA-approved via China's innovative-device channel and FDA 510(k)-cleared for the US market (2023, with a further clearance in 2025).

HeadquartersBeijing, CN
FoundedNot listed
Corporate funding$56M
TeamNot listed
Deployments5
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageUnknown
FoundersWenbo Liu (Co-Founder & CTO), Ke Wang (Co-Founder), Di Wu (Co-Founder)
Regions servedAsia
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

Sinobot X1 (SR1-3D)

  • FDA 510(k) clearance K220072 granted June 18, 2023

    US regulatory market clearance

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2023-08-03Peking University First Hospitalneurosurgical robot installationCNNot disclosedAnnouncement
2023-08-03Peking University Third Hospitalneurosurgical robot installationCNNot disclosedAnnouncement
2023-08-03Children's Hospital of Fudan Universityneurosurgical robot installationCNNot disclosedAnnouncement
2023-08-03Southern Hospital, Southern Medical Universityneurosurgical robot installationCNNot disclosedAnnouncement
2023-08-03Second Affiliated Hospital, Zhejiang University School of Medicineneurosurgical robot installationCNNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordUS-China Green Fund (Yangtze Delta)Cinda KunpengShuimu InvestmentJunshan CapitalHuiyu InvestmentDenuo Capital
TL

Company timeline

Milestones and announcements

2025-11-05Further FDA 510(k) substantial-equivalence determination (K250363)US FDA
2023-06-18FDA 510(k) clearance for neurosurgical robot (K220072)US FDA
SC

Source ledger

4 unique public sources

01
A dark horse gallops out of Beijing in the surgical robot raceTencent News · retrieved 2026-07-05
02
Sinovation Medical completes Series D to advance precision neurosurgeryAlibaba Cloud Startup (syndicated) · retrieved 2026-07-05
03
510(k) K220072 — Sinovation (Beijing) Medical TechnologyUS FDA · retrieved 2026-07-05
04
510(k) K250363 — Beijing Sinovation Medical TechnologyUS FDA · retrieved 2026-07-05